T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ILPT
2051
Industrial Logistics Properties Trust
ILPT
$605M
| $577K | ﹤0.01% |
27,718
+3,131
| +13% | +$62.2K |
|
|
SRDX
2052
DELISTED
Surmodics
SRDX
| $569K | ﹤0.01% |
13,186
+20
| +0.2% | +$844 |
|
2053
8x8 Inc
EGHT
$290M
| $568K | ﹤0.01% |
23,586
+253
| +1% | +$5.89K |
|
2054
Pilgrim's Pride
PPC
$6.4B
| $567K | ﹤0.01% |
22,344
-836,563
| -97% | -$21.7M |
|
2055
Toyota
TM
$223B
| $566K | ﹤0.01% |
4,562
+232
| +5% | +$28.3K |
|
|
MDRX
2056
DELISTED
Veradigm Inc. Common Stock
MDRX
| $566K | ﹤0.01% |
48,702
+348
| +0.7% | +$3.54K |
|
2057
BancFirst
BANF
$3.84B
| $565K | ﹤0.01% |
10,156
+49
| +0.5% | +$2.72K |
|
|
EVRI
2058
DELISTED
Everi Holdings
EVRI
| $564K | ﹤0.01% |
47,255
-9,398
| -17% | -$102K |
|
2059
Designer Brands
DBI
$311M
| $562K | ﹤0.01% |
29,303
+123
| +0.4% | +$2.51K |
|
2060
Metallus
MTUS
$900M
| $560K | ﹤0.01% |
68,830
+100
| +0.1% | +$905 |
|
|
SPN
2061
DELISTED
Superior Energy Services, Inc.
SPN
| $560K | ﹤0.01% |
43,115
+8,300
| +24% | +$244K |
|
|
CRC
2062
DELISTED
California Resources Corporation
CRC
| $559K | ﹤0.01% |
28,418
+210
| +0.7% | +$4.47K |
|
2063
Forward Air
FWRD
$658M
| $558K | ﹤0.01% |
9,440
+63
| +0.7% | +$3.88K |
|
2064
Hyster-Yale Materials Handling
HY
$614M
| $558K | ﹤0.01% |
10,090
+20
| +0.2% | +$1.12K |
|
2065
Arvinas
ARVN
$580M
| $557K | ﹤0.01% |
+25,321
| New | +$532K |
|
2066
Advanced Drainage Systems
WMS
$10.6B
| $557K | ﹤0.01% |
16,984
+96
| +0.6% | +$2.77K |
|
2067
DNOW Inc
DNOW
$3.04B
| $555K | ﹤0.01% |
37,580
+290
| +0.8% | +$4.15K |
|
2068
iShares MSCI United Kingdom ETF
EWU
$4.14B
| $553K | ﹤0.01% |
17,100
+8,000
| +88% | +$263K |
|
2069
Innovative Industrial Properties
IIPR
$1.67B
| $553K | ﹤0.01% |
4,473
+16
| +0.4% | +$1.47K |
|
|
AVYA
2070
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $553K | ﹤0.01% |
46,418
+403
| +0.9% | +$6.16K |
|
|
MAGN
2071
Magnera Corp
MAGN
$443M
| $552K | ﹤0.01% |
2,517
+10
| +0.4% | +$1.99K |
|
|
UHT
2072
Universal Health Realty Income Trust
UHT
$573M
| $551K | ﹤0.01% |
6,489
+26
| +0.4% | +$2.14K |
|
2073
Limoneira
LMNR
$251M
| $550K | ﹤0.01% |
27,575
-9,457
| -26% | -$202K |
|
|
VGR
2074
DELISTED
Vector Group Ltd.
VGR
| $550K | ﹤0.01% |
83,500
+468
| +0.6% | +$3.13K |
|
2075
Applied Industrial Technologies
AIT
$13B
| $546K | ﹤0.01% |
8,877
-29,228
| -77% | -$1.71M |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.